JUN 16, 2020 9:00 AM PDT

Personal Protein Signatures for Precision Medicine

Speaker
  • Founder, CEO and CSO of Atturos Ltd.
    Biography
      Stephen Pennington who is currently Professor of Proteomics at the University college Dublin School of Medicine & Conway Institute in Dublin, Ireland, as well as Founder, CEO and CSO of Atturos Ltd. He graduated from Imperial College London and earned his PhD in Biochemistry from the University of Cambridge. Steve and his research team are actively engaged in a number of collaborative translational clinical proteomics projects using mass spectrometry. Atturos mission is to deliver advanced diagnostic tests to enable clinicians 'make better clinical decisions'. Atturos first 'in house' product is a patented multimarker test - OCProDx - designed to support men diagnosed with prostate cancer and we'll hear more about that in Steve's presentation.

    Abstract

    It is anticipated that the rapidly emerging era of data-driven precision medicine will require the development and delivery of new protein-based tests. Despite significant advances in the use of mass spectrometry for protein quantification, the implementation of new protein signatures is proving very challenging. Some of these challenges and potential solutions will be outlined in the context the precision medicine-orientated and end user driven approach Atturos is using to develop and deliver new protein signature tests with specific intended utility in chronic diseases.

    For Research Use Only. Not for use in diagnostic procedures.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    Loading Comments...
    Show Resources